
Yanghee Woo, M.D., comments on disparities in healthcare for select patients with gastric cancer and describes how these impact the diagnosis and treatment of the disease.

Yanghee Woo, M.D., comments on disparities in healthcare for select patients with gastric cancer and describes how these impact the diagnosis and treatment of the disease.

City of Hope’s Yanghee Woo, M.D., highlights risk factors for gastric cancer and comments on the rise in cases in adults 40 years of age and younger.

View the full CURE® Educated Patient® Webinar: Empowering Patients to Understand Cancer Genetic Testing and Counseling on demand.

Adam J. Schoenfeld, MD, considers the benefits and limitations of tumor-infiltrating lymphocyte (TIL) therapy and discusses its potential impact on the treatment landscape in non–small cell lung cancer.

An expert in the management of non–small cell lung cancer defines tumor-infiltrating lymphocyte (TIL) therapy by discussing its mechanism of action and reviewing its impact in other disease states, such as myeloma.

A key opinion leader in thoracic oncology discusses factors to consider regarding emerging cell therapy options in non–small cell lung cancer, such as CAR T, TCR, and TIL therapies.

Adam J. Schoenfeld, MD, provides key insights into treatment options for patients with non–small cell lung cancer whose tumors progress after first-line therapy.

Bonnie Addario, a lung cancer survivor, explains the importance of comprehensive biomarker testing in patients with lung cancer to treat to target and coverage from insurance companies.

View the entire 2021 Extraordinary Healer® Award for Oncology Nursing virtual presentation here!

View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part I - Diagnosis and Staging on demand.

View the full CURE Educated Patient Multiple Myeloma Summit on demand.

Watch CURE®'s EDUCATED PATIENT® Webinar: Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing.

View the full CURE Educated Patient Women's Cancer Summit on demand.

Watch our Acute Myeloid Leukemia Webinar where an expert panel discussed topics highly relevant to patients, caregivers and advocates right now.

Watch our Myeloproliferative Neoplasms Webinar where an expert panel discussed topics highly relevant to patients, caregivers and advocates right now.

Watch our metastatic colorectal cancer webinar where an expert panel discussed topics highly relevant to nurses as they care for patients and provide support to caregivers.

View all three sessions of the CURE Educated Patient Lung Cancer Summit here!

View the full CURE®Educated Patient® Multiple Myeloma Summit here!

Watch our first colorectal cancer webinar where an expert panel discussed topics highly relevant to patients, caregivers and advocates.

Watch the entire MPN Heroes program here!

View our full first breast cancer webinar where an expert panel discusses topics highly relevant to patients, caregivers and advocates right now.

View the full 2020 CURE® Educated Patient® Lung Webinar on lung cancer here!

View the entire CURE® Educated Patient® Leukemia & Lymphoma Summit. A virtual event seeking to educate, inform and challenge the thinking of patients with leukemia and lymphoma.

At the CURE® EDUCATED PATIENT® Advanced Bladder Cancer Webinar, experts discussed the role nurses play in care for patients with bladder cancer, new treatments and more.

View the entire Extraordinary Healer® Award for Oncology Nursing virtual presentation here!

Watch the entire Ovarian Cancer Heroes program right here!

Watch the entire Lung Cancer Heroes program here!

Join us for our Chronic Lymphocytic Leukemia webinar where experts discuss CLL information highly relevant to patients, caregivers and advocates right now. Participants will have the opportunity to submit questions to be answered live by our expert panel.

On Thursday, September 30, 2020, from 5:30 – 6:30 p.m. ET join CURE® for the next EDUCATED PATIENT® CLL Webinar.

Four exceptional heroes will be honored along with the Lifetime Achievement award winner, who has provided a significant impact in the lung cancer community.